Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Bernhard Gibbs is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 5 Article
-
It's about TIME - Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma
Gibbs, B., C., K., Nzeteu, G. A. N., Hoogwater, F. J. H., Nijkamp, M. W., Bockhorn, M. & Meyer, N. H., 31 Jan 2025, In: Frontiers in Immunology. 16, p. 1495907Research output: Contribution to journal › Article › peer-review
Open AccessFile6 Citations (Scopus) -
Lactate in Anaphylaxis: 100 Years On
Borzova, E. & Gibbs, B., 24 Jul 2025, In: Sports medicine (Auckland, N.Z.). 55, 9, p. 2091-2110Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Ligand-Receptor Interactions of V-domain Ig-Containing Suppressor of T Cell Activation and Programmed Death-1 Suppress the Anti-Cancer Activities of T Cells
Abooali, M., Lei, X., Yasinska, I. M., Schlichtner, S., Hussain, R., Siligardi, G., Gianga, T.-M., Berger, S. M., Cholewa, D., Gibbs, B. F., Fasler-Kan, E. & Sumbayev, V. V., 9 Dec 2025, In: Immuno-Oncology and Technology. p. 101533Research output: Contribution to journal › Article › peer-review
Open Access -
Early-life risk factors which govern pro-allergic immunity.
Ptaschinski, C. & Gibbs, B., 1 Jul 2024, In: Seminars in Immunopathology. 46, 3-4, p. 9Research output: Contribution to journal › Article › peer-review
Open AccessFile6 Citations (Scopus) -
Elucidating allergic reaction mechanisms in response to SARS-CoV-2 mRNA vaccination in adults.
Fulton, W. T., Fernandes, A., Galli, S. J., Durham, S. R., Gibbs, B., Agache, I., Chinthrajah, S., Akdis, C. A., Shamji, M. H., Nadeau, K. C., Shah, M., Layhadi, J. A., Hourcade, D. E., Tan, T. J., Dunham, D., Chang, I., Vel, M. S., Lee, A., Liu, J. & Arunachalam, P. S. & 16 others, , 20 Jul 2024, In: Allergy: European Journal of Allergy and Clinical Immunology.Research output: Contribution to journal › Article › peer-review
Open AccessFile